Search

everythinglearnresearchcommunity

for

Search:↓

A sick foal with Rhodococcus equi pneumonia was successfully treated for multiple complications with targeted therapy and careful monitoring.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Parry–Romberg Syndrome can involve the brain even without obvious symptoms, and a new diagnostic framework is suggested for early detection.

REV7 is crucial for genome stability and cancer treatment, making it a potential target for therapy.

Rapamycin treatment helps with mitochondrial disease by reducing PKC levels.

Different skin treatments work best for different levels of wrinkles and sun damage.

Enteral nutrition's role in maintaining Crohn's disease remission is unclear and needs more research.

Chemical lumbar sympathectomy is an effective and safe treatment for idiopathic livedo reticularis.

Exo.Reset® uses extracellular vesicle technology for skin rejuvenation.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

GRF is not safe for tubal occlusion.

Children with Parry Romberg Syndrome had successful facial fat-grafting surgeries after disease stabilization with no complications.

Ritlecitinib is safe and may effectively treat alopecia areata.

Normal skin cell renewal doesn't need RAR signaling, but vitamin A-related skin thickening does.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

NDP-MSH protects brain cells and reduces inflammation in Parkinson's disease by activating MC1R and involving Tregs.

The treatment improved facial structure and corrected bite issues in patients.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Retinoic acid is effective for treating eruptive vellus hair cysts.

An 80-year-old man grew extra hair on his forearms after starting Alzheimer's medication rivastigmine.

Rare earth elements are crucial in medical imaging and cancer treatment.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

Injecting specific cells into the skin can help improve skin structure and reduce blisters in a genetic skin disorder.

Microneedle arrays deliver botulinum toxin effectively for sweat suppression, similar to injections.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

KSR1 is crucial for certain skin tumor formation and could be a cancer therapy target.

Understanding and careful application of dermabrasion and microdermabrasion can minimize risks and improve patient outcomes.

PRP shows promise for spinal pain but needs more guidelines before widespread use.

Virtual reality can reduce pain during scalp injections.